Země: Austrálie
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
levodopa, Quantity: 150 mg; carbidopa monohydrate, Quantity: 40.5 mg (Equivalent: carbidopa, Qty 37.5 mg); entacapone, Quantity: 200 mg
Medis Pharma Pty Ltd
carbidopa monohydrate,Entacapone,Levodopa
Tablet, film coated
Excipient Ingredients: hyprolose; powdered cellulose; sodium sulfate; trehalose dihydrate; magnesium stearate; carmellose sodium; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin
Oral
100 tablets
(S4) Prescription Only Medicine
levodopa/carbidopa/entacapone is indicated for the management of patients with Parkinson?s disease who are experiencing motor fluctuations.
Visual Identification: Red, oval, biconvex coated tablet with '150' on one side and 'LEC'on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2013-10-03